
About Teliqon Pharmaceutical Private Limited
Data last updated:
Teliqon Pharmaceutical Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2020PTC364984.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Ram Nivas Mishra and Rubi Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ruchi Singh Plot No 03 Kh No 228/2 Groun Floor Manav Kunj Street No – 18 Mukandpur, Delhi, India – 110042.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.2 Lakh, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹1,461 (net margin 0.3%) and EBITDA of ₹4,251 (EBITDA margin 0.8%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years.
The company is associated with 1 brand: Teliqon Pharmaceutical.
Teliqon Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-05-0000975). For more details, the company can be reached via its website teliqonpharma.com.
Company details
Recognitions & Rankings of Teliqon Pharmaceutical
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-05-0000975
Contact details
Teliqon Pharmaceutical Private Limited's registered office is in Delhi, Delhi.
- Registered AddressRuchi Singh Plot No 03 Kh No 228/2 Groun Floor Manav Kunj Street No – 18 Mukandpur, Delhi, India – 110042
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Teliqon Pharmaceutical operates one associated brand: Teliqon Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products and services in healthcare sectors in India. | teliqonpharma.com |
Business activity
The main business activity of Teliqon Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Teliqon Pharmaceutical Private Limited, buy the company report.
Financials of Teliqon Pharmaceutical Private Limited
FY 2025 filings availableTeliqon Pharmaceutical Private Limited reported revenue of ₹5.2 Lakh (down 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 24% over three years, including a 20% fall in the latest year. EBITDA fell 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,251 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,461 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Teliqon Pharmaceutical Private Limited, buy the company report.
Board of directors of Teliqon Pharmaceutical Private Limited
Teliqon Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ram Nivas Mishra | Director | 18 Jun 2020 | 6 Years 5 Months | Current |
| Rubi Kumari | Director | 18 Jun 2020 | 6 Years 5 Months | Current |
Peer comparison
Teliqon Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Proptunity Private Limited | ₹5.2 Lakh (FY 2021) | Ahmedabad, Gujarat, India | ||||
| Miracle Furnish Private Limited | ₹5.2 Lakh (FY 2022) | 89.0% | Bhiwani, Haryana, India | |||
| Ferne Secure Private Limited | ₹5.2 Lakh (FY 2021) | 365.0% | Lucknow, Uttar Pradesh, India | |||
| GD Retail Private Limited | ₹5.2 Lakh (FY 2024) | -46.0% | Kancheepuram, Tamil Nadu, India | |||
| Shriyedoba Farmer Producer Company Limited | ₹5.2 Lakh (FY 2024) | 3.0% | Hingoli, Maharashtra, India | |||
| Teliqon Pharmaceutical Private Limitedthis company | ₹5.2 Lakh (FY 2025) | ₹1,461 | 0.3% | -20.0% | Delhi, India | |
| Sanurti Textiles Private Limited | ₹5.2 Lakh (FY 2023) | -19.0% | Thane, Maharashtra, India | |||
| R K Filaments Private Limited | ₹5.2 Lakh (FY 2025) | -90.0% | Surat, Gujarat, India | |||
| Spoxy Vintrade Private Limited | ₹5.2 Lakh (FY 2020) | Kolkata, West Bengal, India | ||||
| Ganesha Trade Exim Private Limited | ₹5.2 Lakh (FY 2022) | Kolkata, West Bengal, India | ||||
| TCST Building Solutions India Private Limited | ₹5.2 Lakh (FY 2025) | -75.0% | New Delhi, Delhi, India |
To see the full peer comparison of Teliqon Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Teliqon Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Teliqon Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Teliqon Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Teliqon Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ram Nivas Mishra was appointed as Director on 18 Jun 2020.
Frequently asked questions
Teliqon Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 June 2020 (6+ years old) and is registered under CIN U51909DL2020PTC364984.
Teliqon Pharmaceutical has 2 current directors:
- Ram Nivas Mishra - Director
- Rubi Kumari - Director
The latest financial statements of Teliqon Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Teliqon Pharmaceutical is U51909DL2020PTC364984. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Teliqon Pharmaceutical was incorporated on 18 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Teliqon Pharmaceutical by revenue are Proptunity Private Limited, Miracle Furnish Private Limited, Ferne Secure Private Limited, GD Retail Private Limited, Shriyedoba Farmer Producer Company Limited and 5 more, all in the same principal business activity (wholesale trading).
Ram Nivas Mishra was appointed as Director on 18 Jun 2020. Rubi Kumari was appointed as Director on 18 Jun 2020.
Yes, Teliqon Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Teliqon Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-05-0000975).
Teliqon Pharmaceutical can be reached through the website teliqonpharma.com. Its registered office is in Delhi, India.
The registered office of Teliqon Pharmaceutical is at Ruchi Singh Plot No 03 Kh No 2282 Groun Floor Manav Kunj Street No – 18 Mukandpur, Delhi, India – 110042.

